ReviewNanophotonics (Berlin, Germany)2022
Two-dimensional photonic MXene nanomedicine.
Review in Nanophotonics (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering TiRSC advances · 2026Review
- MXene Nanomaterial Interfaces: Pioneering Neural Signal Recording for Brain-Computer Interfaces and Cognitive Therapy.Topics in current chemistry (Cham) · 2026Review
- Novel two-dimensional materials based bio-nanophotonics.Nanophotonics (Berlin, Germany) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two-dimensional (2D) transition metal carbides and nitrides (MXenes) with fascinating physicochemical properties, ultrathin lamellar structure, high specific surface area, and excellent biocompatibility have been extensively explored in biomedical applications over the past decade. Photonic MXene nanomedicine and materdicine, as one of the most burgeoning emerging treatment modalities, are of great research interest owing to their photon utilization ability and high therapeutic efficiency. This review aims to summarize and discuss the very-recent advances in engineering 2D MXenes for photonic theranostic applications. We initially concentrate on the synthesis methods, surface modification, and functionalization with respect to MXenes. Furthermore, the photonic biological applications including photonic antibacteria, photonic bioimaging, photonic therapy, and photonic theranostics are highlighted in detail with the selected paradigms. Finally, the current challenges and future directions for 2D MXene biomaterials in regard to their photonic biomedicines are discussed in depth, aiming to drive the speed of their practical applications in clinic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.